@article{article, title  = {{LBA102 THOR-2 cohort 1: Results of erdafitinib (ERDA) vs intravesical chemotherapy (chemo) in patients (pts) with high-risk non–muscle-invasive bladder cancer (HR NMIBC) with select fibroblast growth factor receptor alterations (FGFRALT) who received prior bacillus calmette-guérin (BCG) treatment}},

 publisher = {{Elsevier BV}},

 url = {{http://dx.doi.org/10.1016/j.annonc.2023.10.108 }},

 year = {{2023}},

 month = {{10}},

 author = {{Catto JWF and Tran B and Roupret M and Gschwend JE and Loriot Y and Nishiyama H and Palou J and Daneshmand S and Hussain SA and Cutuli HJ and Procopio G et al}},

 doi = {{10.1016/j.annonc.2023.10.108}},

 volume = {{34}},

 journal = {{Annals of Oncology}},

 pages = {{S1341-S1342}},

 note = {{Accessed on 2024/12/22}}}